000078.SZ Stock Analysis
00
Uncovered
Shenzhen Neptunus Bioengineering Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Market cap $B
0.819
Dividend yield
0.57 %
Shares outstanding
2 631.12 B
Website
https://www.neptunusbio.com/Shenzhen Neptunus Bioengineering Co., Ltd. engages in the business of pharmaceutical industry. The company is headquartered in Shenzhen, Guangdong and currently employs 9,657 full-time employees. The Company’s main products include anti-tumor products, cardiovascular drugs, marine drugs, respiratory drugs, anti-infective products and other pharmaceuticals, as well as healthcare products, health food and medical instrument. The firm distributes its products mainly in domestic market, with East China as its main market.